MX2021013587A - Sintesis de fases liquidas convergentes de oligonucleotidos. - Google Patents
Sintesis de fases liquidas convergentes de oligonucleotidos.Info
- Publication number
- MX2021013587A MX2021013587A MX2021013587A MX2021013587A MX2021013587A MX 2021013587 A MX2021013587 A MX 2021013587A MX 2021013587 A MX2021013587 A MX 2021013587A MX 2021013587 A MX2021013587 A MX 2021013587A MX 2021013587 A MX2021013587 A MX 2021013587A
- Authority
- MX
- Mexico
- Prior art keywords
- oligonucleotides
- synthesis
- liquid phases
- convergent
- convergent liquid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/02—Phosphorylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962845160P | 2019-05-08 | 2019-05-08 | |
| PCT/US2020/032070 WO2020227618A2 (en) | 2019-05-08 | 2020-05-08 | Convergent liquid phase syntheses of oligonucleotides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021013587A true MX2021013587A (es) | 2022-02-11 |
Family
ID=70919104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021013587A MX2021013587A (es) | 2019-05-08 | 2020-05-08 | Sintesis de fases liquidas convergentes de oligonucleotidos. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12378276B2 (https=) |
| EP (1) | EP3966219A2 (https=) |
| JP (2) | JP7824080B2 (https=) |
| KR (1) | KR20220007104A (https=) |
| CN (3) | CN119462804A (https=) |
| AU (1) | AU2020268415B2 (https=) |
| BR (1) | BR112021022219A2 (https=) |
| CA (1) | CA3139545A1 (https=) |
| EA (1) | EA202193010A1 (https=) |
| IL (2) | IL287798B2 (https=) |
| MA (1) | MA55891A (https=) |
| MX (1) | MX2021013587A (https=) |
| WO (1) | WO2020227618A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013203395A1 (en) | 2012-03-30 | 2013-10-17 | Isis Pharmaceuticals, Inc. | Compositions and methods for modulating TAU expression for reducing seizure and modifying a neurodegenerative syndrome |
| TWI772856B (zh) | 2013-07-19 | 2022-08-01 | 美商百健Ｍａ公司 | 用於調節τ蛋白表現之組合物 |
| AU2021377229A1 (en) | 2020-11-11 | 2023-06-29 | Biogen Ma Inc. | Oligonucleotides, reagents and preparation thereof |
| PE20240648A1 (es) * | 2021-07-23 | 2024-04-04 | Biogen Ma Inc | Metodos para reducir la expresion de tau |
| WO2024083746A1 (en) | 2022-10-17 | 2024-04-25 | Bachem Holding Ag | Method and composition for oligonucleotide synthesis |
| JP7825064B2 (ja) * | 2022-10-27 | 2026-03-05 | 住友化学株式会社 | オリゴヌクレオチドの製造方法 |
| CN120813558A (zh) | 2023-03-06 | 2025-10-17 | 斯佩拉制药株式会社 | 长链烯氧基取代的苯甲酰衍生物及使用该衍生物的寡核苷酸合成方法 |
| GB202305283D0 (en) * | 2023-04-11 | 2023-05-24 | Exactmer Ltd | Liquid-phase process for preparing oligonucleotides |
| JP7433684B1 (ja) * | 2023-05-24 | 2024-02-20 | 塩野フィネス株式会社 | 疑似固相保護基、それを用いたヌクレオシド保護体又はオリゴヌクレオチド保護体、オリゴアミダイト前駆体の製造方法 |
| EP4695265A1 (en) | 2023-10-16 | 2026-02-18 | Bachem Holding AG | Method and composition for oligonucleotide synthesis |
| US20250206769A1 (en) * | 2023-12-22 | 2025-06-26 | Imec Vzw | Synthesizing a Nucleic Acid or Nucleic Acid Analogue |
| WO2025235761A1 (en) | 2024-05-09 | 2025-11-13 | Biogen Ma Inc. | Reagents and processes for preparing oligonucleotides |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0558749A1 (en) * | 1990-11-20 | 1993-09-08 | Sankyo Company Limited | Antisense nucleic acid derivative |
| US5510476A (en) * | 1994-07-07 | 1996-04-23 | Isis Pharmaceuticals, Inc. | Carbocation scavenging during oligonucleotide synthesis |
| AU738032B2 (en) | 1995-10-19 | 2001-09-06 | Proligo Llc | Method for solution phase synthesis of oligonucleotides |
| EP1386925A1 (en) * | 2002-07-31 | 2004-02-04 | Girindus AG | Method for preparing oligonucleotides |
| SI2548560T1 (sl) | 2005-06-23 | 2015-12-31 | Isis Pharmaceuticals, Inc. | Sestavki in postopki za moduliranje izrezovanja smn2 |
| RU2572826C2 (ru) | 2008-12-02 | 2016-01-20 | Чиралджен, Лтд. | Способ синтеза модифицированных по атому фосфора нуклеиновых кислот |
| JP5548852B2 (ja) * | 2009-05-29 | 2014-07-16 | 国立大学法人東京農工大学 | 疎水性基結合ヌクレオシド、疎水性基結合ヌクレオシド溶液、及び疎水性基結合オリゴヌクレオチド合成方法 |
| PT3305302T (pt) | 2009-06-17 | 2018-12-14 | Biogen Ma Inc | Composições e métodos de modulação de excisões de smn2 em um sujeito |
| US20120184724A1 (en) * | 2009-09-22 | 2012-07-19 | Agilent Technologies, Inc. | Protected monomers and methods of deprotection for rna synthesis |
| JP5705512B2 (ja) | 2010-11-26 | 2015-04-22 | 農工大ティー・エル・オー株式会社 | 高分散性液相支持体を用いたオリゴヌクレオチド合成法 |
| JP5979139B2 (ja) * | 2011-05-17 | 2016-08-24 | 味の素株式会社 | オリゴヌクレオチドの製造方法 |
| EP2816053B1 (en) | 2012-02-17 | 2021-03-24 | Ajinomoto Co., Inc. | Base-protected oligonucleotide |
| US8846885B2 (en) * | 2012-02-17 | 2014-09-30 | Ajinomoto Co., Inc. | Oligonucleotide with protected base |
| EP2857412B1 (en) * | 2012-05-30 | 2017-01-11 | Hokkaido System Science Co., Ltd. | Oligonucleotide synthesis method using highly dispersible liquid-phase support |
| EP2921499B1 (en) * | 2012-11-14 | 2020-01-22 | Takeda Pharmaceutical Company Limited | Method for liquid-phase synthesis of nucleic acids |
| RS60707B1 (sr) | 2014-04-01 | 2020-09-30 | Biogen Ma Inc | Kompozicije za modulaciju ekspresije sod-1 |
| EP3263579B1 (en) | 2015-01-21 | 2022-11-30 | Ajinomoto Co., Inc. | Precipitation promoter and precipitation method in which same is used |
| WO2017104836A1 (ja) * | 2015-12-16 | 2017-06-22 | 味の素株式会社 | オリゴヌクレオチドの製造方法、およびヌクレオシド、ヌクレオチドまたはオリゴヌクレオチド |
| JPWO2017111137A1 (ja) * | 2015-12-22 | 2018-10-18 | 味の素株式会社 | オリゴヌクレオチドの製造方法 |
| CN108368166B (zh) | 2015-12-28 | 2023-03-28 | 中外制药株式会社 | 提高含fc区多肽纯化效率的方法 |
| TW201906855A (zh) | 2017-05-02 | 2019-02-16 | 日商日產化學工業股份有限公司 | 寡核苷酸之製造方法 |
-
2020
- 2020-05-08 IL IL287798A patent/IL287798B2/en unknown
- 2020-05-08 KR KR1020217039894A patent/KR20220007104A/ko active Pending
- 2020-05-08 CN CN202411234328.XA patent/CN119462804A/zh active Pending
- 2020-05-08 JP JP2021565931A patent/JP7824080B2/ja active Active
- 2020-05-08 US US17/608,802 patent/US12378276B2/en active Active
- 2020-05-08 MA MA055891A patent/MA55891A/fr unknown
- 2020-05-08 CA CA3139545A patent/CA3139545A1/en active Pending
- 2020-05-08 CN CN202080044020.2A patent/CN114206897B/zh active Active
- 2020-05-08 MX MX2021013587A patent/MX2021013587A/es unknown
- 2020-05-08 EP EP20729413.3A patent/EP3966219A2/en active Pending
- 2020-05-08 AU AU2020268415A patent/AU2020268415B2/en active Active
- 2020-05-08 WO PCT/US2020/032070 patent/WO2020227618A2/en not_active Ceased
- 2020-05-08 EA EA202193010A patent/EA202193010A1/ru unknown
- 2020-05-08 BR BR112021022219A patent/BR112021022219A2/pt unknown
- 2020-05-08 CN CN202411234221.5A patent/CN119143828A/zh active Pending
- 2020-05-08 IL IL319933A patent/IL319933A/en unknown
-
2025
- 2025-07-04 JP JP2025113743A patent/JP2025138846A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MA55891A (fr) | 2022-03-16 |
| WO2020227618A2 (en) | 2020-11-12 |
| KR20220007104A (ko) | 2022-01-18 |
| AU2020268415A1 (en) | 2021-12-23 |
| EP3966219A2 (en) | 2022-03-16 |
| CA3139545A1 (en) | 2020-11-12 |
| EA202193010A1 (ru) | 2022-03-18 |
| WO2020227618A3 (en) | 2021-01-14 |
| AU2020268415B2 (en) | 2026-04-23 |
| US12378276B2 (en) | 2025-08-05 |
| IL287798B1 (en) | 2025-05-01 |
| AU2020268415A8 (en) | 2022-01-20 |
| JP2025138846A (ja) | 2025-09-25 |
| CN114206897B (zh) | 2024-09-20 |
| CN114206897A (zh) | 2022-03-18 |
| IL319933A (en) | 2025-05-01 |
| JP2022531876A (ja) | 2022-07-12 |
| IL287798A (en) | 2022-01-01 |
| BR112021022219A2 (pt) | 2022-03-22 |
| CN119462804A (zh) | 2025-02-18 |
| CN119143828A (zh) | 2024-12-17 |
| WO2020227618A8 (en) | 2020-12-24 |
| US20220348602A1 (en) | 2022-11-03 |
| IL287798B2 (en) | 2025-09-01 |
| JP7824080B2 (ja) | 2026-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021013587A (es) | Sintesis de fases liquidas convergentes de oligonucleotidos. | |
| CY1123289T1 (el) | Ενωσεις ολιγονουκλεοτιδιων για τη στοχευση του huntingtin mrna | |
| CL2020003028A1 (es) | Anticuerpos anti-cd33, anticuerpos bispecíficos anti-cd33/anti-cd3 y sus usos. | |
| CO2019007046A2 (es) | Moléculas de unión a antígeno biespecíficas que comprenden el clon 20h4.9 anti-4-1bb | |
| BR112014009066B8 (pt) | molécula de ácido nucleico, método para a sintetização de uma molécula de dna de triciclo-fosforotioato e composição farmacêutica | |
| EA033012B1 (ru) | Способ и устройство для превращения сырой нефти в продукты нефтехимического синтеза, характеризующегося улучшенным выходом по этилену и бтк | |
| WO2017079498A3 (en) | Nucleotide analogues | |
| BR112017024555A2 (pt) | moduladores de ccr2 | |
| EA201492119A1 (ru) | Композиции и способы для модулирования экспрессии apoa1 и abca1 | |
| AR088883A1 (es) | Moleculas de union para bcma y cd3 | |
| EP3995581A3 (en) | Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders | |
| BR112019003314A2 (pt) | métodos para acoplamento cruzado | |
| MX2022015258A (es) | Anticuerpos anti-cxcr5 y composiciones y usos de los mismos. | |
| FR3023840B1 (fr) | Procede de production de paraxylene a haute purete a partir d'une coupe xylenes, utilisant deux unites de separation en lit mobile simule fonctionnant en serie et deux unites d'isomerisation. | |
| MX2018002665A (es) | Combinacion que comprende oligonucleotidos inmunoestimulantes. | |
| CL2014002661A1 (es) | Compuestos derivados de tienopirimidina o sus sales, como inhibidores de la alk quinasa; su proceso de preparacion; composicion farmaceutica que los comprende, util para el tratamiento del cancer. | |
| BR112016025196A2 (pt) | composições de oligonucleotídeo e métodos de fazê-las | |
| HK1254367A1 (zh) | 新的工艺和中间体 | |
| EP3375522A4 (en) | METHOD FOR PRODUCING A DEHYDRATION CATALYST FOR LIGHTWEIGHT HYDROCARBONS WITH ROLLED CHAIN MEMBERS USING A STABILIZED ACTIVE MATERIAL COMPLEX | |
| BR112017005856A2 (pt) | reação de carboxilação de fluxo contínuo | |
| MX381562B (es) | Proceso para aislar y purificar ambrox. | |
| MX2017000023A (es) | Proceso para preparar fenilalcanos sustituidos. | |
| MX2018011052A (es) | Compuestos y metodos para la sintesis de fosforamidato de 5-(n-triptamina carboxamida protegida)-2'-desoxiuridina para ser incorporados en una secuencia nucleica. | |
| CL2025000292A1 (es) | Anticuerpos tmem219 y usos terapéuticos de los mismos | |
| BR112016030604B8 (pt) | Processo para preparação de ácidos 3- hidroxipicolínicos |